Next Article in Journal
Comparative Transcriptomic Analysis of the Development of Sepal Morphology in Tomato (Solanum Lycopersicum L.)
Next Article in Special Issue
Role of Muscle-Specific Histone Methyltransferase (Smyd1) in Exercise-Induced Cardioprotection against Pathological Remodeling after Myocardial Infarction
Previous Article in Journal
Na+, K+-ATPase α Isoforms and Endogenous Cardiac Steroids in Prefrontal Cortex of Bipolar Patients and Controls
Previous Article in Special Issue
Corin Overexpression Reduces Myocardial Infarct Size and Modulates Cardiomyocyte Apoptotic Cell Death

Linking LOXL2 to Cardiac Interstitial Fibrosis

Biomedical Research and Innovation Platform, South African Medical Research Council, Cape Town 7501, South Africa
Department of Medical Physiology, Stellenbosch University, Cape Town 7505, South Africa
Hatter Institute for Cardiovascular Research in Africa (HICRA), University of Cape Town, Cape Town 7925, South Africa
Hospices Civils de Lyon, Hôpital Edouard Herriot, Service de Médecine Intensive-Réanimation, Place d’Arsonval, 69437 Lyon, France
Institute de Investigación Sanitaria-FJD, Faculty of Medicine, University Autónoma de Madrid, 28049 Madrid, Spain
Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM) Network, 28040 Madrid, Spain
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2020, 21(16), 5913;
Received: 8 July 2020 / Revised: 23 July 2020 / Accepted: 29 July 2020 / Published: 18 August 2020
(This article belongs to the Special Issue Myocardial Infarction and Myocardial Protection)
Cardiovascular diseases (CVDs) are the leading causes of death worldwide. CVD pathophysiology is often characterized by increased stiffening of the heart muscle due to fibrosis, thus resulting in diminished cardiac function. Fibrosis can be caused by increased oxidative stress and inflammation, which is strongly linked to lifestyle and environmental factors such as diet, smoking, hyperglycemia, and hypertension. These factors can affect gene expression through epigenetic modifications. Lysyl oxidase like 2 (LOXL2) is responsible for collagen and elastin cross-linking in the heart, and its dysregulation has been pathologically associated with increased fibrosis. Additionally, studies have shown that, LOXL2 expression can be regulated by DNA methylation and histone modification. However, there is a paucity of data on LOXL2 regulation and its role in CVD. As such, this review aims to gain insight into the mechanisms by which LOXL2 is regulated in physiological conditions, as well as determine the downstream effectors responsible for CVD development. View Full-Text
Keywords: Lysyl Oxidase-Like 2 (LOXL2); epigenetics; DNA methylation; fibrosis; cardiovascular disease (CVD) Lysyl Oxidase-Like 2 (LOXL2); epigenetics; DNA methylation; fibrosis; cardiovascular disease (CVD)
Show Figures

Figure 1

MDPI and ACS Style

Erasmus, M.; Samodien, E.; Lecour, S.; Cour, M.; Lorenzo, O.; Dludla, P.; Pheiffer, C.; Johnson, R. Linking LOXL2 to Cardiac Interstitial Fibrosis. Int. J. Mol. Sci. 2020, 21, 5913.

AMA Style

Erasmus M, Samodien E, Lecour S, Cour M, Lorenzo O, Dludla P, Pheiffer C, Johnson R. Linking LOXL2 to Cardiac Interstitial Fibrosis. International Journal of Molecular Sciences. 2020; 21(16):5913.

Chicago/Turabian Style

Erasmus, Melisse, Ebrahim Samodien, Sandrine Lecour, Martin Cour, Oscar Lorenzo, Phiwayinkosi Dludla, Carmen Pheiffer, and Rabia Johnson. 2020. "Linking LOXL2 to Cardiac Interstitial Fibrosis" International Journal of Molecular Sciences 21, no. 16: 5913.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop